| Ms Sarah Church, PSYD | |
|
24330 Narbonne Ave, Lomita, CA 90717-1131 | |
| (310) 534-1083 | |
| Not Available |
| Full Name | Ms Sarah Church |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 24330 Narbonne Ave, Lomita, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881897650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY23209 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sarah Church, PSYD 24330 Narbonne Ave, Lomita, CA 90717-1131 Ph: (310) 534-1083 | Ms Sarah Church, PSYD 24330 Narbonne Ave, Lomita, CA 90717-1131 Ph: (310) 534-1083 |
News Archive
Theravance Biopharma, Inc. and Mylan Inc. today announced that the two companies will partner on the development and, subject to FDA approval, commercialization of TD-4208, a novel investigational once-daily nebulized long-acting muscarinic antagonist (LAMA) for chronic obstructive pulmonary disease (COPD) and other respiratory diseases.
A former Centers for Medicare and Medicaid Services administrator told the Senate Finance Committee Wednesday that Medicare should focus on fewer quality measures in their assessments, letting patient outcomes dictate what constitutes quality care instead.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
The world's biggest study offering healthy eating and exercise advice to pregnant women who are overweight or obese has shown a significant reduction in the number of babies born over 4kg (8.8 pounds) in weight.
Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.
› Verified 6 days ago
Dr. Randi M. Gunther, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2075 Palos Verdes Dr N Ste 218, Lomita, CA 90717 Phone: 310-325-3873 Fax: 310-325-9302 | |
Harris Stuart Halpern, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2081 Palos Verdes Dr N, Lomita, CA 90717 Phone: 310-517-3486 | |
Ji Yun Nam, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2081 Palos Verdes Dr N, Lomita, CA 90717 Phone: 310-325-6542 Fax: 310-534-6045 |